Bioprocessing of human platelet concentrates to generate lysates and extracellular vesicles for therapeutic applications
Author:
Yeh Wei-Ting,
Yu Ezrin Yi-Ling,
Lu Ya-Hsuan,
Livkisa Dora,
Burnouf Thierry,
Lundy David J.ORCID
Reference23 articles.
1. Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery;Burnouf;J. Biomed. Sci.,2023
2. Human platelet lysate for good manufacturing practice-compliant cell production;Oeller;Int. J. Mol. Sci,2021
3. Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion;Shih;N. Biotechnol,2015
4. Platelet-derived drug delivery systems: pioneering treatment for cancer, cardiovascular diseases, infectious diseases, and beyond;Zhu;Biomaterials,2024
5. Platelet extracellular vesicles and their mitochondrial content improve the mitochondrial bioenergetics of cellular immune recipients;Pelletier;Transfusion,2023